United StatesOverall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Dermatology & Venereal Diseases
SubField 2:
General & Internal Medicine
Rank in SubField 1: 355 out of 54,095 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 56,505 | 60,725 |
| Total Cites | 9,137 | 9,777 |
| H-index | 48 | 49 |
| Hm-index | 24 | 26 |
| Number of Single Authored Papers | 11 | 11 |
| Total Cites to Single Authored Papers | 56 | 62 |
| Number of Single+First Authored Papers | 70 | 70 |
| Total Cites to Single+First Authored Papers | 1,889 | 2,060 |
| Number of Single+First+Last Authored Papers | 185 | 185 |
| Total Cites to Single+First+Last Authored Papers | 4,624 | 4,940 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 7,476 | 7,802 |
| Ratio of Total Citations to Distinct Citing Papers | 1.22 | 1.25 |
| Self-Citation Percentage |
6.55%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Dermatology & Venereal Diseases
SubField 2:
General & Internal Medicine
Rank in SubField 1: 399 out of 51,411 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 63,444 | 67,455 |
| Total Cites | 7,989 | 8,580 |
| H-index | 44 | 46 |
| Hm-index | 22 | 24 |
| Number of Single Authored Papers | 10 | 10 |
| Total Cites to Single Authored Papers | 46 | 50 |
| Number of Single+First Authored Papers | 68 | 68 |
| Total Cites to Single+First Authored Papers | 1,699 | 1,866 |
| Number of Single+First+Last Authored Papers | 181 | 181 |
| Total Cites to Single+First+Last Authored Papers | 4,065 | 4,366 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 6,527 | 6,819 |
| Ratio of Total Citations to Distinct Citing Papers | 1.22 | 1.26 |
| Self-Citation Percentage |
6.89%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Dermatology & Venereal Diseases
SubField 2:
General & Internal Medicine
Rank in SubField 1: 409 out of 49,699 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 64,813 | 69,663 |
| Total Cites | 7,453 | 8,023 |
| H-index | 43 | 44 |
| Hm-index | 21 | 23 |
| Number of Single Authored Papers | 10 | 10 |
| Total Cites to Single Authored Papers | 44 | 48 |
| Number of Single+First Authored Papers | 66 | 66 |
| Total Cites to Single+First Authored Papers | 1,579 | 1,741 |
| Number of Single+First+Last Authored Papers | 175 | 175 |
| Total Cites to Single+First+Last Authored Papers | 3,825 | 4,118 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 6,079 | 6,358 |
| Ratio of Total Citations to Distinct Citing Papers | 1.23 | 1.26 |
| Self-Citation Percentage |
7.10%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Dermatology & Venereal Diseases
SubField 2:
General & Internal Medicine
Rank in SubField 1: 433 out of 41,196 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 66,297 | 70,762 |
| Total Cites | 6,421 | 6,945 |
| H-index | 40 | 43 |
| Hm-index | 20 | 21 |
| Number of Single Authored Papers | 10 | 10 |
| Total Cites to Single Authored Papers | 41 | 45 |
| Number of Single+First Authored Papers | 66 | 66 |
| Total Cites to Single+First Authored Papers | 1,445 | 1,603 |
| Number of Single+First+Last Authored Papers | 171 | 171 |
| Total Cites to Single+First+Last Authored Papers | 3,352 | 3,634 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 5,263 | 5,509 |
| Ratio of Total Citations to Distinct Citing Papers | 1.22 | 1.26 |
| Self-Citation Percentage |
7.54%
|
|
Trending Researchers
.jpeg)
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.